Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) will release its third quarter fiscal year 2023 financial results on February 7, 2023, at 6:00 AM ET. A conference call for investors and analysts will follow at 8:00 AM ET on the same day, allowing participants to discuss the results and ask questions. Registration is required to access the call, and a live webcast will also be available on the company's investor relations website. A replay of the call will be accessible for one year post the event.

Positive

• Scheduled release of Q3 FY2023 financial results indicates ongoing transparency.
• Conference call engagement signals commitment to investor relations.

Negative

• None.

BOSTON, Jan. 6, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2023 financial results at 6:00 am ET on Tuesday, February 7, 2023. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 7, 2023.

The call can be accessed via teleconference at: Q3 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnof https://edge.media-server.com/mmc/p/pt8ugsbv 

A replay of the conference call and webcast will be available for one year beginning on February 7, 2023 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact: 
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com

Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2023-results-february-7-2023-301715719.html

SOURCE Haemonetics Corporation

FAQ

What date will Haemonetics announce their Q3 FY2023 financial results?

Haemonetics will announce their Q3 fiscal year 2023 financial results on February 7, 2023.

What time is the Haemonetics Q3 FY2023 earnings call?

The earnings call for Haemonetics will take place at 8:00 AM ET on February 7, 2023.

How can I access the Haemonetics earnings call?

Participants can register to access the Haemonetics earnings call and receive a dial-in number.

Where can I find the live webcast of Haemonetics' Q3 results?

The live webcast of Haemonetics' Q3 results will be available on their investor relations website.

Will there be a replay of the Haemonetics earnings call?

Yes, a replay of the Haemonetics earnings call will be available for one year beginning on February 7, 2023.